Lupin Limited (LUPIN.NS) Financial Analysis & Valuation | Quarter Chart
Lupin Limited (LUPIN.NS)
LUPIN.NSPrice: $23.66
Fair Value: 🔒
🔒score
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatric... more
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded a... more
Description
Shares
| Market Cap | $10.82B | Exchange | NSE |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | IN | CEO | Vinita D. Gupta |
| IPO Date | 2001-09-10 | CAGR | 0.15% |
| Employees | 19,210 | Website | www.lupin.com |
| Div. Yield | 0.04% | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | 0.04% |
LUPIN.NS chart loading...
Fundamentals
Technicals
| Enterprise Value | $885.64B | P/E Ratio | 19.62 |
| Forward P/E | 22.47 | PEG Ratio | 0.22 |
| P/S Ratio | 962.81 | P/B Ratio | 1277.51 |
| P/CF Ratio | — | P/FCF Ratio | — |
| EPS | $1.21 | EPS Growth 1Y | 63.24% |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 12.4% | Gross Margin | 0.69% |
| Operating Margin | 0.26% | Profit Margin | 0.16% |
| ROE | 0.22% | ROA | — |
| ROCE | — | Current Ratio | — |
| Quick Ratio | — | Cash Ratio | — |
| Debt/Equity | — | Interest Coverage | 18.75 |
| Altman Z Score | — | Piotroski Score | 3 |